Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025

Q1 FY25 results · Apr–Jun 2024

Advanced Enzyme Technologies reported revenue from operations of ₹154.52 crore (up 4.9% from Q1 FY24) and net profit of ₹34.98 crore (up 19.1% from Q1 FY24) for Q1 FY25 (Apr–Jun 2024), on a consolidated basis.

Consolidated · ₹ crore
ItemQ1 FY25Q1 FY24YoYQ4 FY24QoQ
Revenue from operations154.52147.28+4.9%157.81−2.1%
Other income6.996.67+4.8%9.50−26.4%
Total income161.52153.95+4.9%167.31−3.5%
Profit before tax48.6741.41+17.6%39.61+22.9%
Net profit for the period34.9829.38+19.1%29.87+17.1%
Attributable to shareholders of the company34.1528.81+18.5%28.31+20.6%
EPS, basic (₹)3.052.58+18.2%2.53+20.6%
Net margin (%)22.619.918.9
Standalone · ₹ crore
ItemQ1 FY25Q1 FY24YoYQ4 FY24QoQ
Revenue from operations85.9685.35+0.7%92.40−7.0%
Other income53.8851.25+5.1%3.2117x
Total income139.83136.60+2.4%95.61+46.2%
Profit before tax72.1673.48−1.8%10.39+594.4%
Net profit for the period67.0667.49−0.6%3.1421x
EPS, basic (₹)6.006.04−0.7%0.2821x
Net margin (%)78.079.13.4
Consolidated
Filed with BSE
13 Aug 2024, 14:28 IST
Board meeting
10 Aug 2024
Period
01 Apr 2024 to 30 Jun 2024
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
13 Aug 2024, 14:28 IST
Board meeting
10 Aug 2024
Period
01 Apr 2024 to 30 Jun 2024
Review status
Unaudited
Source
XBRL filing on BSE